Statistics
Stimulant Use and Related Harms in Canada: Recent Trends
Instrument for Pre-accession Assistance (IPA) data sheets
Leveraging National Surveillance Networks for Local Action and Collective Impact
Featuring: Dr. Samantha King, CCSA Research and Policy Analyst
Conceptualising drug market-related violence
Date: 16 June 2026, 14:30–16:00 Lisbon time (WEST) — 15:30–17:00 (CEST).
Objective: This webinar seeks to inform participants on the concept of drug market-related violence, how to conceptualise it and how to measure it.
Ketamine in Europe
Objective: This webinar aims to provide insights into the European ketamine market and will expand on health-related harms caused by non-medical ketamine use.
Launch event: European Drug Report 2026
Join us for the launch of the European Drug Report 2026: Trends and Developments on 9 June 2026. The report delivers the latest evidence on the state of the drugs problem in Europe.
Time: 09:00 WEST (Lisbon), 10:00 CEST (Brussels) (NB time to be confirmed)
CCENDU Issue 7 (Part 2): Stimulant Use and Related Harms in Canada — Drivers and Adaptive Responses
CCENDU Issue 7 (Part 1): Stimulant Use and Related Harms in Canada - Recent Trends
EUDA webinar: International drug checking day
Objective: Taking place on the eve of International Drug Checking Day, this webinar offers a timely opportunity to highlight the role drug-checking services play across three domains: harm reduction, drug market monitoring and public health alerts. The session will demonstrate the benefits of drug checking for a variety of stakeholders, including consumers, public health authorities and monitoring bodies.